Chemoinformaics analysis of cis-13-Eicosenoic acid methyl ester
| Molecular Weight | 324.549 | nRot | 17 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 2 |
| Exact Molecular Weight | 324.303 | nRing | 0 |
| Solubility: LogS | -6.911 | nHRing | 0 |
| Solubility: LogP | 8.357 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 63.3457 |
| nHD | 0 | BPOL | 42.7323 |
| QED | 0.164 |
| Synth | 2.099 |
| Natural Product Likeliness | 0.664 |
| NR-PPAR-gamma | 0.222 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.004 |
| CACO-2 | -4.791 |
| MDCK | 0.0000145 |
| BBB | 0.113 |
| PPB | 0.974917 |
| VDSS | 3.52 |
| FU | 0.0167255 |
| CYP1A2-inh | 0.396 |
| CYP1A2-sub | 0.184 |
| CYP2c19-inh | 0.379 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.196 |
| CYP2c9-sub | 0.956 |
| CYP2d6-inh | 0.246 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.453 |
| CYP3a4-sub | 0.044 |
| CL | 5.33 |
| T12 | 0.186 |
| hERG | 0.292 |
| Ames | 0.005 |
| ROA | 0.01 |
| SkinSen | 0.973 |
| Carcinogencity | 0.086 |
| EI | 0.954 |
| Respiratory | 0.68 |
| NR-Aromatase | 0.108 |
| Antiviral | No |
| Prediction | 0.590773 |